Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications

Molecular and Cellular Proteomics

Volumn 10, Issue 6, 2011, Pages

  Chen, Jianxiang ^a   Wei, Dongping ^a   Zhuang, Hongqin ^a   Qiao, Yiting ^a   Tang, Bo ^a   Zhang, Xiangyu ^a   Wei, Jing ^a   Fang, Shentong ^a   Chen, Guo ^a   Du, Pan ^a   Huang, Xiaofeng ^a   Jiang, Wenhui ^a   Hu, Qingang ^a   Hua, Zi Chun ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; ANTINEOPLASTIC AGENT; BACTERIAL PROTEIN; ENDOSTATIN; HYPOXIA INDUCIBLE FACTOR; LUCIFERASE; UNCLASSIFIED DRUG; VNP 20009; ANGIOGENESIS INHIBITOR; HYBRID PROTEIN; PROTEOME;

ANAEROBIC GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE CONTROL; GENE EXPRESSION; LEWIS CARCINOMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MELANOMA; MOUSE; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEOMICS; SALMONELLA TYPHIMURIUM; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; ANIMAL; BIOLOGICAL THERAPY; C57BL MOUSE; CANCER TRANSPLANTATION; CELL DEATH; CELL HYPOXIA; CHICK EMBRYO; CHORIOALLANTOIS; EXPERIMENTAL MELANOMA; GENETICS; KAPLAN MEIER METHOD; METABOLISM; METHODOLOGY; NUCLEOTIDE SEQUENCE; PATHOLOGY; TRANSGENIC ORGANISM; TUMOR CELL LINE; TUMOR VOLUME; UPREGULATION; VASCULARIZATION;

ANIMALIA; MURINAE; MUS; SALMONELLA; SALMONELLA TYPHIMURIUM;

ALCOHOL DEHYDROGENASE; ANAEROBIOSIS; ANGIOGENESIS INHIBITORS; ANIMALS; BACTERIAL PROTEINS; BASE SEQUENCE; BIOLOGICAL THERAPY; CARCINOMA, LEWIS LUNG; CELL DEATH; CELL HYPOXIA; CELL LINE, TUMOR; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; ENDOSTATINS; FEMALE; KAPLAN-MEIER ESTIMATE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; ORGANISMS, GENETICALLY MODIFIED; PROMOTER REGIONS, GENETIC; PROTEOME; RECOMBINANT FUSION PROTEINS; SALMONELLA TYPHIMURIUM; TUMOR BURDEN; UP-REGULATION;

EID: 79957987053     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.009399     Document Type: Article

References (35)

1. Clairmont, C., Lee, K. C., Pike, J., Ittensohn, M., Low, K. B., Pawelek, J., Bermudes, D., Brecher, S. M., Margitich, D., Turnier, J., Li, Z., Luo, X., King, I., and Zheng, L. M. (2000) Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J. Inf. Dis. 181, 1996-2002
2. Toso, J. F., Gill, V. J., Hwu, P., Marincola, F. M., Restifo, N. P., Schwartzentruber, D. J., Sherry, R. M., Topalian, S. L., Yang, J. C., Stock, F., Freezer, L. J., Morton, K. E., Seipp, C., Haworth, L., Mavroukakis, S., White, D., MacDonald, S., Mao, J., Sznol, M., and Rosenberg, S. A. (2002) Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J. Clin. Oncol. 20, 142-152
3. Luo, X., Li, Z., Lin, S., Le, T., Ittensohn, M., Bermudes, D., Runyab, J. D., Shen, S. Y., Chen, J., King, I. C., and Zheng, L. M. (2001) Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models. Oncol. Res. 12, 501-508
4. Low, K. B., Ittensohn, M., Luo, X., Zheng, L. M., King, I., Pawelek, J. M., and Bermudes, D. (2004) Construction of VNP20009: a novel, genetically stable antibiotic-sensitive strain of tumor-targeting Salmonella for parenteral administration in humans. Methods Mol. Med. 90, 47-60
5. Bermudes, D., Zheng, L. M., and King, I. C. (2002) Live bacteria as anticancer agents and tumor-selective protein delivery vectors. Curr. Opin. Drug Discov. Develop. 5, 194-199
6. Zheng, L. M., Luo, X., Feng, M., Li, Z., Le, T., Ittensohn, M., Trailsmith, M., Bermudes, D., Lin, S. L., and King, I. C. (2000) Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector. Oncol. Res. 12, 127-135
7. Soghomonyan, S. A., Doubrovin, M., Pike, J., Luo, X., Ittensohn, M., Runyan, J. D., Balatoni, J., Finn, R., Tjuvajev, J. G., Blasberg, R., and Bermudes, D. (2005) Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK. Cancer Gene Ther. 12, 101-108 (Pubitemid 39665248)
8. Forbes, N. S., Munn, L. L., Fukumura, D., and Jain, R. K. (2003) Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. Cancer Res. 63, 5188-5193
9. King, I., Bermudes, D., Lin, S., Belcourt, M., Pike, J., Troy, K., Le, T., Ittensohn, M., Mao, J., Lang, W. S., Runyan, J. D., Luo, X., Li, Z. J., and Zheng, L. M. (2002) Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent. Human Gene Ther. 13, 1225-1233
10. Low, K. B., Ittensohn, M., Le, T., Platt, J., Sodi, S., Amoss, M., Ash, O., Carmichael, E., Chakraborty, A., Fischer, J., Lin, S. L., Luo, X., Miller, S. I., Zheng, L., King, I., Pawelek, J. M., and Bermudes, D. (1999) Lipid A mutant Salmonella with suppressed virulence and TNF alpha induction retain tumor-targeting in vivo. Nat. Biotechnol. 17, 37-41
11. Hautefort, I., Proença, M. J., and Hinton, J. C. (2003) Single-copy green fluorescent protein gene fusions allow accurate measurement of Salmonella gene expression in vitro and during infection of mammalian cells. Appl. Environ. Microbiol. 69, 7480-7491
12. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. (1997) Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285 (Pubitemid 28015876)
13. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390, 404-407
14. Eder, J. P., Jr, Supko, J. G., Clark, J. W., Puchalski, T. A., Garcia-Carbonero, R., Ryan, D. P., Shulman, L. N., Proper, J., Kirvan, M., Rattner, B., Connors, S., Keogan, M. T., Janicek, M. J., Fogler, W. E., Schnipper, L., Kinchla, N., Sidor, C., Phillips, E., Folkman, J., and Kufe, D. W. (2002) Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J. Clin. Oncol. 20, 3772-3784
15. Herbst, R., Hess, K., Mulliani, N., Charnsangavej, C., Baker, C., Ellis, L., Kim, E., Bucana, C., Pluda, J., Fidler, I., and Abbruzzese, J. (2000) A phase I clinical trial of recombinant human endostatin (rHE) in patients (PTS) with solid tumors: Surrogate analyses to determine a biologically effective dose (BED). Clin.Cancer Res. 6, 4582S
16. Jia, L. J., Xu, H. M., Ma, D. Y., Hu, Q. G., Huang, X. F., Jiang, W. H., Li, S. F., Jia, K. Z., Huang, Q. L., and Hua, Z. C. (2005) Enhanced therapeutic effect by combination of tumor-targeting Salmonella and endostatin in murine melanoma model. Cancer Biol. Ther. 4, 840-845
17. Philippe, N., Alcaraz, J. P., Coursange, E., Geiselmann, J., and Schneider, D. (2004) Improvement of pCVD442, a suicide plasmid for gene allele exchange in bacteria. Plasmid 51, 246-255 (Pubitemid 38510371)
18. Gahan, M. E., Webster, D. E., Wesselingh, S. L., and Strugnell, R. A. (2007) Impact of plasmid stability on oral DNA delivery by Salmonella enterica serovar Typhimurium. Vaccine 25, 1476-1483
19. Li, C., Tan, Y. X., Zhou, H., Ding, S. J., Li, S. J., Ma, D. J., Man, X. B., Hong, Y., Zhang, L., Li, L., Xia, Q. C., Wu, J. R., Wang, H. Y., and Zeng, R. (2005) Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markers. Proteomics 5, 1125-1139 (Pubitemid 40469040)
20. Yu, L. R., Zeng, R., Shao, X. X., Wang, N., Xu, Y. H., and Xia, Q. C. (2000) Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 21, 3058-3068
21. Yang, W., Liu, P., Liu, Y., Wang, Q., Tong, Y., and Ji, J. (2006) Proteomic analysis of rat pheochromocytoma PC12 cells. Proteomics 6, 2982-2990 (Pubitemid 43806397)
22. Gobom, J., Schuerenberg, M., Mueller, M., Theiss, D., Lehrach, H., and Nordhoff, E. (2001) alpha-cyano-4-hydroxycinnamic acid affinity sample preparation. A protocol for MALDI-MS peptide analysis in proteomics. Analyt. Chem. 73, 434-438
23. Tomilov, A. A., Bicocca, V., Schoenfeld, R. A., Giorgio, M., Migliaccio, E., Ramsey, J. J., Hagopian, K., Pelicci, P. G., and Cortopassi, G. A. (2010) Decreased Superoxide Production in Macrophages of Long-lived p66Shc Knock-out Mice. J. Biol. Chem. 285, 1153-1165
24. Sun, Q. M., Cao, L., Fang, L., Chen, C., Dai, J., Chen, L. L., and Hua, Z. C. (2005) Expression, purification of human vasostatin120-180 in Escherichia coli, and its anti-angiogenic characterization. Protein Exp. Purification 39, 288-295
25. Jia, L. J., Wei, D. P., Sun, Q. M., Jin, G. H., Li, S. F., Huang, Y., and Hua, Z. C. (2007) Tumor-targeting Salmonella typhimurium improves cyclophosphamide chemotherapy at maximum tolerated dose and low-dose metronomic regimens in a murine melanoma model. Int. J. Cancer 121, 666-674
26. Ganai, S., Arenas, R. B., and Forbes, N. S. (2009) Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. Br. J. Cancer 101, 1683-1691
27. Chang, C. C., Lin, M. T., Lin, B. R., Jeng, Y. M., Chen, S. T., Chu, C. Y., Chen, R. J., Chang, K. J., Yang, P. C., and Kuo, M. L. (2006) Effect of connective tissue growth factor on hypoxia-inducible factor 1 alpha degradation and tumour angiogenesis. J. Natl. Cancer Inst. 98, 984-995
28. Spinella, F., Rosano, L., Di Castro, V., Decandia, S., Albini, A., Nicotra, M. R., Natali, P. G., and Bagnato, A. (2006) Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Mol. Cancer Therap. 5, 1483-1492 (Pubitemid 44070485)
29. Soma, T., Kaganoi, J., Kawabe, A., Kondo, K., Tsunoda, S., Imamura, M., and Shimada, Y. (2006) Chenodeoxycholic acid stimulates the progression of human esophageal cancer cells: A possible mechanism of angiogenesis in patients with esophageal cancer. Int. J. Cancer 119, 771-782 (Pubitemid 44051440)
30. Brown, J. M. (2000) Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol. Med. Today 6, 157-162
31. Dailly, Y. P., Bunch, P., and Clark, D. P. (2000) Comparison of the fermentative alcohol dehydrogenases of Salmonella typhimurium and Escherichia coli. Microbios 103, 179-196
32. Crawford, M. J., and Goldberg, D. E. (1998) Regulation of the Salmonella typhimurium flavohemoglobin gene. A new pathway for bacterial gene expression in response to nitric oxide. J. Biol. Chem. 273, 34028-34032
33. Folkman, J. (2006) Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action. Exp. Cell Res. 312, 594-607
34. Bannerman, D. D., Tupper, J. C., Ricketts, W. A., Bennett, C. F., Winn, R. K., and Harlan, J. M. (2001) A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis. J. Biol. Chem. 276, 14924-14932
35. Lee, C. H., Wu, C. L., and Shiau, A. L. (2004) Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models. J. Gene Med. 6, 1382-1393